TWST RSI Chart
Last 7 days
35.0%
Last 30 days
28.1%
Last 90 days
13.1%
Trailing 12 Months
227.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 277.5M | 0 | 0 | 0 |
2023 | 227.8M | 235.5M | 245.1M | 262.4M |
2022 | 163.1M | 184.2M | 203.6M | 215.8M |
2021 | 113.0M | 126.8M | 132.3M | 146.2M |
2020 | 65.8M | 73.4M | 90.1M | 101.1M |
2019 | 40.0M | 47.1M | 54.4M | 60.1M |
2018 | 18.1M | 21.8M | 25.4M | 32.6M |
2017 | 0 | 0 | 10.8M | 14.4M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 03, 2024 | finn patrick john | sold | -85,816 | 37.134 | -2,311 | president and coo |
May 03, 2024 | banyai william | sold | -29,632 | 37.134 | -798 | see remark |
May 03, 2024 | werner robert f. | sold | -4,901 | 37.134 | -132 | chief accounting officer |
May 03, 2024 | leproust emily m. | sold | -154,589 | 37.134 | -4,163 | chief executive officer |
May 03, 2024 | cho dennis | sold | -21,092 | 37.134 | -568 | see remarks |
May 03, 2024 | green paula | sold | -33,791 | 37.134 | -910 | svp of human resources |
Apr 23, 2024 | finn patrick john | sold | -65,483 | 30.121 | -2,174 | president and coo |
Apr 09, 2024 | laponis adam | sold | -18,434 | 33.155 | -556 | chief financial officer |
Apr 02, 2024 | green paula | sold | -7,496 | 32.736 | -229 | svp of human resources |
Apr 02, 2024 | finn patrick john | sold | -16,106 | 32.736 | -492 | president and coo |
Which funds bought or sold TWST recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 08, 2024 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | reduced | -1.15 | -10,447,600 | 120,401,000 | 0.31% |
May 08, 2024 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | added | 14.84 | -317,343 | 281,227 | -% |
May 08, 2024 | Eagle Bay Advisors LLC | unchanged | - | -118 | 1,578 | -% |
May 08, 2024 | KBC Group NV | added | 49.74 | 17,000 | 59,000 | -% |
May 08, 2024 | US BANCORP \DE\ | reduced | -18.39 | -10,695 | 33,795 | -% |
May 08, 2024 | Russell Investments Group, Ltd. | added | 53.7 | 858 | 2,848 | -% |
May 08, 2024 | PROFUND ADVISORS LLC | added | 1.64 | -74,781 | 1,311,670 | 0.05% |
May 08, 2024 | Entropy Technologies, LP | added | 62.22 | 167,826 | 496,912 | 0.05% |
May 08, 2024 | ProShare Advisors LLC | added | 10.19 | 12,412 | 495,573 | -% |
May 08, 2024 | ISTHMUS PARTNERS, LLC | unchanged | - | -34,068 | 458,382 | 0.05% |
Unveiling Twist Bioscience Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Twist Bioscience Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 186.3B | 23.7B | 42.31 | 7.85 | ||||
A | 42.5B | 6.7B | 34.41 | 6.31 | ||||
IDXX | 41.4B | 3.7B | 47.74 | 11.11 | ||||
DGX | 15.3B | 9.3B | 18.14 | 1.65 | ||||
MEDP | 12.4B | 2.0B | 39.59 | 6.3 | ||||
CRL | 11.9B | 4.1B | 27.01 | 2.88 | ||||
NTRA | 11.5B | 1.1B | -26.55 | 10.67 | ||||
EXAS | 10.0B | 2.5B | -41.57 | 3.94 | ||||
MID-CAP | ||||||||
NEOG | 2.7B | 929.2M | 1.7K | 2.9 | ||||
GH | 2.4B | 603.7M | -5.17 | 3.95 | ||||
SMALL-CAP | ||||||||
CDNA | 576.0M | 275.1M | -3.14 | 2.09 | ||||
ACRS | 87.7M | 31.1M | -1.13 | 2.82 | ||||
APDN | 63.5M | 9.0M | -8.79 | 7.06 | ||||
AWH | 37.9M | 9.2M | -2.27 | 4.14 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Twist Bioscience Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 5.3% | 75,302,000 | 71,498,000 | 66,946,000 | 63,740,000 | 60,180,000 | 54,243,000 | 57,306,500 | 56,113,000 | 48,127,000 | 42,018,000 | 37,950,500 | 35,018,000 | 31,204,000 | 28,161,000 | 32,432,000 | 21,207,000 | 19,297,000 | 17,164,000 | 15,736,500 | 13,600,000 | 13,557,000 |
Cost Of Revenue | 4.4% | 44,420,000 | 42,536,000 | 42,424,000 | 41,845,000 | 41,669,000 | 29,442,000 | 31,586,000 | 30,974,000 | 29,714,000 | 27,056,000 | 22,497,000 | 20,933,000 | 19,028,000 | 18,162,000 | 17,577,500 | 16,472,000 | 13,564,000 | 13,792,000 | 12,385,500 | 11,394,000 | 11,789,000 |
Costs and Expenses | 4.8% | 124,191,000 | 118,475,000 | 117,057,500 | 124,521,000 | 121,817,000 | 98,873,000 | 114,177,500 | 117,276,000 | 108,929,000 | 97,958,000 | 77,761,500 | 77,136,000 | 69,208,000 | 60,954,000 | 56,399,000 | 49,403,000 | 51,383,000 | 72,994,000 | 47,305,000 | 41,721,000 | 39,820,000 |
S&GA Expenses | 5.3% | 55,622,000 | 52,840,000 | 47,391,500 | 46,057,000 | 53,965,000 | 42,324,000 | 54,159,500 | 53,693,000 | 53,998,000 | 51,098,000 | 38,242,500 | 34,478,000 | 34,389,000 | 28,792,000 | 27,185,000 | 22,487,000 | 27,190,000 | 26,405,000 | 24,423,000 | 21,320,000 | 19,124,000 |
R&D Expenses | 4.5% | 24,149,000 | 23,099,000 | 23,745,500 | 24,528,000 | 27,379,000 | 31,242,000 | 29,606,000 | 36,840,000 | 31,231,000 | 22,630,000 | 19,443,000 | 19,838,000 | 15,791,000 | 14,000,000 | 11,636,500 | 10,444,000 | 10,629,000 | 10,297,000 | 10,496,500 | 9,007,000 | 8,907,000 |
EBITDA Margin | 13.5% | -0.57 | -0.66 | -0.71 | -0.77 | -0.83 | -0.91 | -1.04 | -1.11 | -1.15 | -1.14 | -1.09 | -1.01 | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | 1,000 | 1,000 | 2,000 | 1,000 | 25,500 | - | 29,000 | 26,000 | 83,500 | 70,000 | 95,000 | 118,000 | 143,000 | 181,000 | 215,000 | 248,000 | 287,500 | 318,000 | 340,000 |
Income Taxes | 187.5% | 345,000 | 120,000 | -222,000 | 622,000 | 676,000 | 76,000 | 292,000 | -149,000 | -149,000 | -10,405,000 | 340,500 | -2,377,000 | 61,000 | 46,000 | 262,500 | 21,000 | 61,000 | 37,000 | 112,000 | 54,000 | 84,000 |
Earnings Before Taxes | -5.3% | -45,147,000 | -42,888,000 | -46,465,000 | -56,773,000 | -58,480,000 | -41,748,000 | -50,823,000 | -60,666,000 | -60,817,000 | -55,968,000 | -40,901,500 | -42,414,000 | -37,858,000 | -32,854,000 | -24,055,500 | -28,186,000 | -31,707,000 | -55,601,000 | -31,069,000 | -27,862,000 | -25,849,000 |
EBT Margin | 11.6% | -0.69 | -0.78 | -0.83 | -0.88 | -0.93 | -0.99 | -1.12 | -1.19 | -1.23 | -1.21 | -1.16 | -1.08 | - | - | - | - | - | - | - | - | - |
Net Income | -5.8% | -45,492,000 | -43,008,000 | -46,243,000 | -57,395,000 | -59,156,000 | -41,824,000 | -51,115,000 | -60,517,000 | -60,668,000 | -45,563,000 | -41,242,000 | -40,037,000 | -37,919,000 | -32,900,000 | -24,318,000 | -28,207,000 | -31,768,000 | -55,638,000 | -31,181,000 | -27,916,000 | -25,933,000 |
Net Income Margin | 11.7% | -0.69 | -0.78 | -0.83 | -0.89 | -0.93 | -0.99 | -1.07 | -1.13 | -1.15 | -1.13 | -1.15 | -1.07 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 18.2% | -20,026,000 | -24,479,000 | -23,097,000 | -27,921,000 | -53,341,000 | -65,894,000 | -17,729,000 | -74,767,000 | -74,310,000 | -59,436,000 | -42,892,000 | -34,902,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -4.1% | 703 | 733 | 776 | 810 | 854 | 910 | 961 | 980 | 1,022 | 786 | 702 | 725 | 677 | 700 | 399 | 408 | 324 | 192 | 187 | 207 | 140 |
Current Assets | -4.7% | 372 | 390 | 424 | 446 | 489 | 542 | 596 | 624 | 664 | 385 | 546 | 577 | 608 | 634 | 335 | 345 | 260 | 129 | 160 | 183 | 121 |
Cash Equivalents | -7.5% | 246 | 266 | 286 | 307 | 315 | 319 | 380 | 378 | 409 | 193 | 467 | 477 | 401 | 350 | 94.00 | 209 | 185 | 27.00 | 47.00 | 69.00 | 29.00 |
Inventory | -1.6% | 30.00 | 31.00 | 32.00 | 36.00 | 40.00 | 45.00 | 39.00 | 43.00 | 45.00 | 40.00 | 32.00 | 21.00 | 16.00 | 13.00 | 12.00 | 13.00 | 11.00 | 7.00 | 7.00 | 5.00 | 4.00 |
Net PPE | -3.9% | 121 | 126 | 132 | 141 | 147 | 145 | 139 | 127 | 92.00 | 65.00 | 44.00 | 38.00 | 32.00 | 27.00 | 25.00 | 24.00 | 23.00 | 21.00 | 21.00 | 20.00 | 15.00 |
Goodwill | 0% | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 84.00 | 22.00 | 23.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 0.0% | 143 | 143 | 153 | 153 | 150 | 164 | 172 | 159 | 158 | 140 | 121 | 115 | 63.00 | 62.00 | 63.00 | 59.00 | 60.00 | 89.00 | 35.00 | 31.00 | 25.00 |
Current Liabilities | 3.5% | 67.00 | 65.00 | 73.00 | 73.00 | 72.00 | 84.00 | 91.00 | 93.00 | 85.00 | 80.00 | 63.00 | 55.00 | 40.00 | 37.00 | 36.00 | 31.00 | 30.00 | 58.00 | 30.00 | 25.00 | 19.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 2.00 | 3.00 | 4.00 | 4.00 | 5.00 | 6.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 2.00 | 3.00 | 4.00 | 4.00 | 5.00 | 6.00 |
Shareholder's Equity | -5.1% | 560 | 590 | 623 | 658 | 704 | 746 | 789 | 821 | 863 | 626 | 581 | 610 | 614 | 638 | 336 | 349 | 264 | 103 | 152 | 176 | 115 |
Retained Earnings | -4.2% | -1,121 | -1,076 | -1,033 | -986 | -929 | -870 | -828 | -777 | -716 | -656 | -610 | -569 | -529 | -491 | -458 | -434 | -405 | -374 | -318 | -287 | -259 |
Additional Paid-In Capital | 0.9% | 1,682 | 1,667 | 1,657 | 1,645 | 1,633 | 1,617 | 1,620 | 1,599 | 1,581 | 1,282 | 1,191 | 1,179 | 1,143 | 1,129 | 795 | 783 | 670 | 477 | 470 | 463 | 375 |
Shares Outstanding | 0.7% | 58.00 | 58.00 | 58.00 | 57.00 | 57.00 | 56.00 | 57.00 | 56.00 | 52.00 | 50.00 | 48.00 | 48.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 833 | - | - | - | 2,390 | - | - | - | 4,885 | - | - | - | 1,088 | - | - | - | 402 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 15.5% | -19,423 | -22,973 | -20,704 | -23,412 | -44,288 | -54,070 | -1,267 | -34,125 | -42,340 | -46,653 | -34,803 | -27,960 | -24,549 | -24,932 | -25,202 | -23,468 | -58,671 | -34,914 | -23,358 | -22,082 | -20,813 |
Share Based Compensation | 25.4% | 13,824 | 11,020 | 11,747 | 10,597 | 10,259 | -2,325 | 19,048 | 20,043 | 22,465 | 18,108 | 9,247 | 9,176 | 11,553 | 7,022 | 5,131 | 4,071 | 4,197 | 3,697 | 3,363 | 3,032 | 2,911 |
Cashflow From Investing | -225.8% | -5,240 | 4,165 | -2,247 | 18,670 | 41,160 | -6,971 | 2,783 | 4,163 | -13,294 | -226,582 | 23,911 | 104,575 | 73,590 | -45,921 | -94,669 | -61,149 | 28,763 | 12,405 | -1,187 | -22,706 | -15,160 |
Cashflow From Financing | 224.1% | 1,828 | -1,473 | 442 | -661 | 1,525 | -395 | 1,240 | -1,311 | 271,616 | -1,011 | 1,575 | -765 | 1,451 | 326,921 | 5,574 | 108,064 | 188,037 | 2,057 | 2,928 | 84,285 | -1,634 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |||
Statement of Comprehensive Income [Abstract] | ||||||
Revenues | [1] | $ 75,302 | $ 60,180 | $ 146,800 | $ 114,423 | |
Operating expenses: | ||||||
Cost of revenues | 44,420 | 41,669 | 86,955 | 71,111 | ||
Research and development | 24,149 | 27,379 | 47,249 | 58,621 | ||
Selling, general and administrative | 55,622 | 53,965 | 108,462 | 96,289 | ||
Change in fair value of contingent considerations and holdbacks | 0 | (1,196) | 0 | (5,331) | ||
Total operating expenses | 124,191 | 121,817 | 242,666 | 220,690 | ||
Loss from operations | (48,889) | (61,637) | (95,866) | (106,267) | ||
Interest income | 3,941 | 3,464 | 8,061 | 6,504 | ||
Interest expense | 0 | (2) | 0 | (3) | ||
Other income (expense), net | (199) | (305) | (230) | (462) | ||
Loss before income taxes | (45,147) | (58,480) | (88,035) | (100,228) | ||
Income tax provision | (345) | (676) | (465) | (752) | ||
Net loss attributable to common stockholders | (45,492) | (59,156) | (88,500) | (100,980) | ||
Other comprehensive loss: | ||||||
Change in unrealized gain (loss) on investments | (57) | 647 | 77 | 1,516 | ||
Foreign currency translation adjustment | (38) | 73 | 19 | 438 | ||
Comprehensive loss | $ (45,587) | $ (58,436) | $ (88,404) | $ (99,026) | ||
Net loss per share attributable to common stockholders—basic (in usd per share) | $ (0.79) | $ (1.04) | $ (1.54) | $ (1.78) | ||
Net loss per share attributable to common stockholders—diluted (in usd per share) | $ (0.79) | $ (1.04) | $ (1.54) | $ (1.78) | ||
Weighted average shares used in computing net loss per share attributable to common stockholders—basic (in shares) | 57,779 | 56,777 | 57,637 | 56,608 | ||
Weighted average shares used in computing net loss per share attributable to common stockholders—diluted (in shares) | 57,779 | 56,777 | 57,637 | 56,608 | ||
|
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Sep. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 243,348 | $ 286,470 |
Short-term investments | 49,994 | 49,943 |
Accounts receivable, net | 35,993 | 44,064 |
Inventories | 30,376 | 32,063 |
Prepaid expenses and other current assets | 12,158 | 11,716 |
Total current assets | 371,869 | 424,256 |
Property and equipment, net | 121,339 | 131,830 |
Operating lease right-of-use assets | 63,666 | 71,531 |
Goodwill | 85,811 | 85,811 |
Intangible assets, net | 51,898 | 54,483 |
Restricted cash, non-current | 2,868 | 2,811 |
Other non-current assets | 5,395 | 5,681 |
Total assets | 702,846 | 776,403 |
Current liabilities: | ||
Accounts payable | 7,703 | 14,052 |
Accrued expenses | 14,513 | 10,754 |
Accrued compensation | 25,214 | 25,818 |
Current portion of operating lease liability | 14,621 | 14,896 |
Other current liabilities | 5,439 | 7,803 |
Total current liabilities | 67,490 | 73,323 |
Operating lease liability, net of current portion | 74,804 | 79,173 |
Other non-current liabilities | 421 | 475 |
Total liabilities | 142,715 | 152,971 |
Commitments and contingencies (Note 6) | ||
Stockholders’ equity | ||
Common stock, $0.00001 par value —100,000 and 100,000 shares authorized at March 31, 2024 and September 30, 2023, respectively; 58,162 and 57,557 shares issued and outstanding at March 31, 2024 and September 30, 2023, respectively | 0 | 0 |
Additional paid-in capital | 1,682,473 | 1,657,222 |
Accumulated other comprehensive income | (660) | (756) |
Accumulated deficit | (1,121,682) | (1,033,034) |
Total stockholders’ equity | 560,131 | 623,432 |
Total liabilities and stockholders’ equity | $ 702,846 | $ 776,403 |